Children’s Minnesota, the state’s largest pediatric healthcare provider, has announced it will cease prescribing puberty blockers and hormone treatments to minors starting February 27, 2026.
Thank you for reading this post, don't forget to subscribe!This decision marks a major pivot for an institution that has long been a hub for gender-affirming care in the Midwest.
The “Funding vs. Care” Dilemma
The hospital’s leadership characterized the move as a forced choice rather than a medical one. The primary drivers include:
- Federal Funding Mandates: The Trump administration recently moved to block Medicaid and Medicare reimbursements for any hospital systems providing gender-transition drugs to minors.
- A Massive Financial Hit: With nearly half of its patients relying on Medicaid, Children’s Minnesota officials stated that losing federal support would “cripple” the hospital’s ability to provide general pediatric care, emergency services, and cancer treatments.
- Legal Scrutiny: The hospital is currently navigating federal investigations into how these specific treatments were billed and coded in the past.
Scope of the Policy Change
“We are making this change with a heavy heart, solely to ensure the survival of our entire healthcare system.” – Summary of hospital leadership sentiment.
| Continuing Services | Suspended Services |
| Mental health therapy and counseling | New prescriptions for puberty blockers |
| Ongoing support for social transitions | New prescriptions for cross-sex hormones |
| General pediatric medical care | Refills for existing minor patients (post-Feb 27) |
The “Refuge State” Conflict
This move creates a unique legal paradox. Minnesota remains a “Trans Refuge” state under the 2023 law signed by Governor Walz, which protects families seeking this care from state-level bans in places like Iowa or the Dakotas.
However, state law cannot force a private hospital to provide a service, nor can it prevent the federal government from pulling its own funding. This has left many families who moved to Minnesota specifically for this care in a state of sudden uncertainty.
